Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avital Beig

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|May 24, 2022
Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation methodAvital Beig, Rose Ackermann, Yan Wang, et al.
Frontiers in Pharmacology|November 10, 2016
Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability InterplayAvital Beig, David Lindley, Jonathan M Miller, et al.
The AAPS Journal|February 17, 2017
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the PermeabilityAvital Beig, Noa Fine-Shamir, David Lindley, et al.
The AAPS Journal|December 18, 2012
The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneArik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, et al.
Molecular Pharmaceutics|May 29, 2012
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeabilityJonathan M Miller, Avital Beig, Robert A Carr, et al.
Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2011
Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionalityJing Sun, Jonathan M Miller, Avital Beig, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Journal of Pharmaceutical Sciences|July 29, 2018
Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability ValuesOmri Wolk, Milica Markovic, Daniel Porat, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|May 24, 2022
Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation methodAvital Beig, Rose Ackermann, Yan Wang, et al.
Frontiers in Pharmacology|November 10, 2016
Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability InterplayAvital Beig, David Lindley, Jonathan M Miller, et al.
The AAPS Journal|February 17, 2017
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the PermeabilityAvital Beig, Noa Fine-Shamir, David Lindley, et al.
The AAPS Journal|December 18, 2012
The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneArik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, et al.
Molecular Pharmaceutics|May 29, 2012
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeabilityJonathan M Miller, Avital Beig, Robert A Carr, et al.
Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2011
Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionalityJing Sun, Jonathan M Miller, Avital Beig, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Journal of Pharmaceutical Sciences|July 29, 2018
Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability ValuesOmri Wolk, Milica Markovic, Daniel Porat, et al.
Pageof 3